Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunohistochemistry”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Not applicableStudy completedNCT06421207
What this trial is testing

Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

Who this might be right for
HistopathologyWrinkleRhytides
Cytrellis Biosystems, Inc. 6
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Not applicableStudy completedNCT02338427
What this trial is testing

Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis

Who this might be right for
Amyloidosis
Centre Hospitalier Departemental Vendee 140
Not applicableUnknownNCT05446415
What this trial is testing

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Who this might be right for
Severe ObesityType 2 Diabetes Mellitus in Obese
University of Sao Paulo General Hospital 20
Not applicableUnknownNCT05460312
What this trial is testing

Protein Kinase A in Prostate Cancer Tissue.

Who this might be right for
Prostate NeoplasmInflammationBenign Hyperplasia of Prostate
Ziv Hospital 100
Not applicableUnknownNCT02843412
What this trial is testing

The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry

Who this might be right for
Gastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue Blocks
Shanghai Zhongshan Hospital 2,000
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Not applicableUnknownNCT05794737
What this trial is testing

Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma

Who this might be right for
Colorectal Cancer
Sohag University 60
Not applicableStudy completedNCT06644521
What this trial is testing

Angiogenic Factors in the Placentas of Women With COVID-19

Who this might be right for
COVID-19Placenta DiseasesAngiogenesis
Celal Bayar University 40
Not applicableLooking for participantsNCT04622462
What this trial is testing

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Who this might be right for
Oral Neoplasm
Proteocyte Diagnostics Inc. 500
Not applicableUnknownNCT04279327
What this trial is testing

Cell Block Immunohistochemistry in Effusion Cytology

Who this might be right for
Effusion PleuralAscitesPericardial Effusion
Assiut University 100
Not applicableStudy completedNCT03319641
What this trial is testing

PSMA-PET Imaging for Advanced ACC/SDC

Who this might be right for
Salivary Gland CancerAdenoid Cystic CarcinomaSalivary Duct Carcinoma
Radboud University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT01229150
What this trial is testing

Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...

Who this might be right for
Non Small Cell Lung Carcinoma
National Cancer Institute (NCI) 89
Not applicableUnknownNCT00662064
What this trial is testing

Pharmacology and Physiology of the Lower Urinary Tract

Who this might be right for
Urologic Diseases
University College London Hospitals 200
Not applicableStudy completedNCT02535026
What this trial is testing

An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants

Who this might be right for
Breast Cancer
Hoffmann-La Roche 580
Not applicableStudy completedNCT06698055
What this trial is testing

Muscle Adaptations in Children and Adults Following Twelve Weeks of Flywheel or Weight Stack Resistance Exercise

Who this might be right for
Resistance ExerciseMuscle HypertrophySkeletal Muscle+4 more
Björn Alkner 91
Not applicableStudy completedNCT04669951
What this trial is testing

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Who this might be right for
Esophagus Cancer, Adenocarcinoma
Michael Patrick Achiam 100
Testing effectiveness (Phase 2)Ended earlyNCT01531764
What this trial is testing

BIBW 2992 (Afatinib) and Vinorelbine

Who this might be right for
Carcinoma Breast Stage IV
University of Magdeburg 2
Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Not applicableStudy completedNCT03824431
What this trial is testing

High Definition Endoscopy With NBI. Contribution in Patients With Non-erosive Esophagitis

Who this might be right for
GERD
University of Sao Paulo General Hospital 70
Load More Results